Cooper Companies, Inc. (The) (NYSE:COO) declared a semiannual dividend on Friday, July 7th, Wall Street Journal reports. Shareholders of record on Friday, July 21st will be given a dividend of 0.03 per share by the medical device company on Monday, August 7th. This represents a yield of 0.02%. The ex-dividend date is Wednesday, July 19th.

Cooper Companies, Inc. (The) has a dividend payout ratio of 0.6% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Cooper Companies, Inc. (The) to earn $10.61 per share next year, which means the company should continue to be able to cover its $0.06 annual dividend with an expected future payout ratio of 0.6%.

Shares of Cooper Companies, Inc. (NYSE COO) traded down 0.43% during trading on Tuesday, hitting $243.59. The stock had a trading volume of 148,817 shares. The stock has a 50-day moving average price of $245.16 and a 200 day moving average price of $212.73. Cooper Companies, Inc. has a 12 month low of $158.73 and a 12 month high of $256.39. The company has a market cap of $11.90 billion, a P/E ratio of 36.52 and a beta of 0.61.

Cooper Companies, Inc. (The) (NYSE:COO) last announced its quarterly earnings data on Thursday, June 1st. The medical device company reported $2.50 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.25 by $0.25. The company had revenue of $522.40 million for the quarter, compared to analyst estimates of $520.71 million. Cooper Companies, Inc. (The) had a return on equity of 15.88% and a net margin of 16.02%. The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.05 EPS. Equities analysts expect that Cooper Companies, Inc. will post $9.63 EPS for the current fiscal year.

COO has been the topic of several research analyst reports. J P Morgan Chase & Co reissued a “neutral” rating and set a $206.00 price target (up previously from $200.00) on shares of Cooper Companies, Inc. (The) in a research note on Monday, June 5th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $250.00 target price (up previously from $220.00) on shares of Cooper Companies, Inc. (The) in a research note on Saturday, June 3rd. Zacks Investment Research upgraded Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $243.00 price target for the company in a report on Tuesday, May 23rd. BMO Capital Markets reiterated a “buy” rating and issued a $255.00 price target on shares of Cooper Companies, Inc. (The) in a report on Thursday, July 13th. Finally, Oppenheimer Holdings, Inc. set a $225.00 price target on Cooper Companies, Inc. (The) and gave the company a “hold” rating in a report on Saturday, June 3rd. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $242.00.

In other Cooper Companies, Inc. (The) news, Director Stanley Md Zinberg sold 816 shares of the company’s stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $243.14, for a total value of $198,402.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Carol R. Kaufman sold 44,092 shares of the company’s stock in a transaction dated Thursday, June 8th. The shares were sold at an average price of $242.81, for a total transaction of $10,705,978.52. Following the completion of the transaction, the executive vice president now directly owns 60,419 shares of the company’s stock, valued at $14,670,337.39. The disclosure for this sale can be found here. Over the last quarter, insiders sold 67,331 shares of company stock valued at $16,400,454. 1.60% of the stock is owned by insiders.

TRADEMARK VIOLATION WARNING: This report was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was illegally stolen and republished in violation of United States and international copyright laws. The original version of this report can be read at

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Dividend History for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Stock Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related stocks with our FREE daily email newsletter.